Skip to main content
. 2020 Nov 1;45(3):294–300. doi: 10.5114/ceji.2020.101251

Table 3.

Comparison of baseline characteristics, AMCase gene expression, IL-8 gene expression, serum levels of AMCase, and IL-8 among control group, patients with M PAR, and patients with M/S PAR

Variable Control M PAR M/S PAR
AMCase gene expression 1.4 ±1.15 2.81 ±1.2 4.13 ±3.32
IL-8 gene expression 1.01 ±0.53 2.25 ±0.95 4.04 ±3.06
Serum AMCase level 17.89 ±2.98 19.97 ±3.65 23.79 ±2.78
Serum IL-8 level 10.1 ±3.21 14.41 ±2.22 26.08 ±3.35

Results are shown as mean ±SD